Sam Dickie: FDA approval is the main obstacle for A2 - Heather du Plessis-Allan Drive

A2 milk's currently trying to join the race to patch up the infant formula shortage in the US. 
This comes after some challenging conditions in its main market of China for A2 of late with birth rates dropping and strict pandemic restrictions.  
So, what does all this mean for investors? 
Sam Dickie from Fisher Funds joined Heather du Plessis-Allan. 
LISTEN ABOVE

See omnystudio.com/listener for privacy information.